Tumor growth attenuating effect of celastrol in systemic malignancies. (Q53118440)

11 May 2018

title

Tumor growth attenuating effect of celastrol in systemic malignancies. (English)

1 reference

11 May 2018

author name string

Shailendra Kapoor

series ordinal

1

1 reference

11 May 2018

language of work or name

English

0 references

publication date

14 June 2016

1 reference

11 May 2018

International Journal of Cancer

published in

1 reference

11 May 2018

volume

139

1 reference

11 May 2018

issue

6

1 reference

11 May 2018

page(s)

1431

1 reference

11 May 2018

ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway.

cites work

1 reference

Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo.

21 January 2018

1 reference

miR-224 is critical for celastrol-induced inhibition of migration and invasion of hepatocellular carcinoma cells.

21 January 2018

1 reference

Novel celastrol derivatives inhibit the growth of hepatocellular carcinoma patient-derived xenografts

21 January 2018

1 reference

Natural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaB

21 January 2018

1 reference

Celastrol suppresses tumor cell growth through targeting an AR-ERG-NF-κB pathway in TMPRSS2/ERG fusion gene expressing prostate cancer

21 January 2018

1 reference

Celastrol blocks interleukin-6 gene expression via downregulation of NF-κB in prostate carcinoma cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.30151

1 reference

11 May 2018

PubMed ID

27097353

1 reference

11 May 2018